Emergent Health Corp

Equities

EMGE

US29100Q3083

Delayed OTC Markets Other stock markets 12:15:15 2024-05-21 pm EDT			5-day change	1st Jan Change
0.0014 ^USD	0.00%		-6.67%	+100.00%

2023	Emergent Health Corp. Appoints Charlie McMenamin to Its Board of Director	CI
2023	Emergent Health Corp agreed to acquire Nanosthetic Corp.	CI

Clover Capital Partners LLC and Parcae Capital Corporation, Investment Arm completed the acquisition of controlling stake of Emergent Health Corp.

August 26, 2014 at 12:00 am EDT

Clover Capital Partners LLC and Parcae Capital Corporation, Investment Arm entered into an agreement to acquire controlling stake of Emergent Health Corp (OTCPK:EMGE) on November 12, 2013. Post acquisition, Emergent Health will become a fully compliant reporting entity and will apply for upgradation from the OTC Markets exchange.

Clover Capital Partners LLC and Parcae Capital Corporation, Investment Arm completed the acquisition of controlling stake of Emergent Health Corp (OTCPK:EMGE) on August 26, 2014. Current Board of Directors Emergent Health resigned. Stephen A Hussey is now Chief Executive Officer of Emergent Health.

Latest news about Emergent Health Corp

Emergent Health Corp. Appoints Charlie McMenamin to Its Board of Director	23-01-31	CI
Emergent Health Corp agreed to acquire Nanosthetic Corp.	23-01-25	CI
Emergent Health Corp. Reports Revenue Results for the Quarter Ending December 31, 2022	23-01-05	CI
Emergent Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-12-22	CI
Emergent Executes Letter of Intent to Partner with Lumina to Commence Its "Content Based Marketing" Initiative Through Influencers	22-11-23	CI
Emergent Health Corp completed the acquisition of Evolutionary Biologics, Inc.	22-08-08	CI
Emergent Health Corp completed the acquisition of Pressure BioSciences, Inc..	22-08-01	CI
Emergent Health Corp (OTCPK : EMGE) executed a Letter of Intent to acquire Evolutionary Biologics, Inc.	22-07-18	CI
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	22-07-08	CI
Emergent Health Corp executed a Letter of Intent to acquire Pressure BioSciences, Inc.	22-07-05	CI
Emergent Health Corp entered into a binding letter of intent to acquire Fusion Specialty Pharmacy, Inc.	22-06-28	CI
Emergent Health Corp. Appoints Marvin Segel as Director and the Chief Marketing Officer	22-02-15	CI
Emergent Health Corp Announces Executive Changes	22-02-09	CI
Emergent Health Corp acquired PharmaZu LLC.	22-01-31	CI
Emergent Medical Foods Seeks IPO	20-08-04	CI
Emergent Health Corp announced that it expects to receive $0.25 million in funding	20-08-03	CI
Emergent Health Corp announced that it has received $0.1 million in funding	18-07-24	CI
Emergent Health Corp announced a financing transaction	18-07-19	CI
Emergent Health Corp announced that it has received $0.115 million in funding	16-01-20	CI
Emergent Health Corp announced a financing transaction	15-10-07	CI
Emergent Health Corp. Announces Management Changes	15-09-18	CI
Emergent Health Corp. Appoints Kevin Harrington to Board of Directors	15-01-06	CI
Emergent Health Corp Announces Board Appointments	15-01-05	CI
Emergent Health Corp. Changes its Corporate Office Address	14-11-13	CI
Clover Capital Partners LLC and Parcae Capital Corporation, Investment Arm completed the acquisition of controlling stake of Emergent Health Corp.	14-08-26	CI

Chart Emergent Health Corp

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data